Company intelligence / Profile preview

CellType

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

CellType is a biotechnology company focused on developing a platform for the discovery and development of cell-type-specific medicines. By leveraging high-throughput screening, machine learning, and synthetic biology, the company aims to create therapies that precisely target specific cell types and states while sparing healthy tissue. Their approach is designed to improve the efficacy and safety of various modalities, including cell and gene therapies. CellType's technology seeks to address complex diseases such as cancer and autoimmune disorders by identifying unique cellular signatures for therapeutic intervention.

Therapeutic areas: OncologyImmunologyRare Diseases
Modalities: Cell therapyGene therapySmall molecule
Industry: Biotech

Beyond the preview

Go deeper on CellType.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CellType.

Explore the full profile